Long-term follow-up of MRI markers (central vein sign and paramagnetic rim lesions) in multiple sclerosis
Official title: Central Vein Sign in Multiple Sclerosis Extension Study
Run by The Cleveland Clinic · NCT07424027 · Data updated 2026-11-12
This project will test whether two MRI markers—the central vein sign (CVS) and paramagnetic rim lesions (PRL)—help diagnose and track people with multiple sclerosis over 48 months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 3 sites (Los Angeles, California and 2 other locations) |
| Status | Recruiting |
| Started | October 7, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | February 20, 2026 |
| Trial ID | NCT07424027 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with suspected or confirmed multiple sclerosis who completed the original CAVS‑MS two‑year visits, can give informed consent, and can safely undergo MRI are the intended participants.
✕Probably not a fit
People who did not participate in the original CAVS‑MS, who have MRI contraindications (e.g., incompatible metal implants), or who cannot tolerate MRI (severe claustrophobia or excessive movement) are not eligible and are unlikely to benefit from this extension.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a 48-month extension of the CAVS‑MS effort that will follow 40 participants at three U.S. centers to collect serial MRIs and compare CVS and PRL findings over time. Participants who completed the 24‑month CAVS‑MS visit will undergo additional MRI visits, including contrast-enhanced sequences, to document lesion characteristics and changes. The study will measure how well CVS helps distinguish MS lesions from mimics and whether PRLs predict clinical course or lesion evolution. Results will provide pilot longitudinal data to inform a larger multicenter follow-up effort.
Why it matters
Potential benefit: If successful, these MRI markers could make diagnosis more accurate and help doctors monitor disease activity over time, which may lead to earlier or better-tailored treatment.
How similar studies have gone: Numerous cross-sectional studies have shown the CVS reliably distinguishes MS lesions from common mimics and PRLs are a promising marker, but long-term longitudinal data are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must be enrolled in and meet all inclusion criteria of the CAVS-MS study. * Must have participated in the CAVS-MS study and have completed month 24 visits. * Able to provide written informed consent to participate in the study. Exclusion Criteria: * Contraindication to MRI studies; metal or metal implants incompatible with MRI * Inability to tolerate MRI due to claustrophobia or known excessive movement (e.g. tremor).
Where it's running
-
Cleveland Clinic Foundation
Cleveland, Ohio, United States Recruiting -
Cedars-Sinai Medical Center
Los Angeles, California, United States Not yet recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Not yet recruiting
Study contacts
- Principal investigator: Daniel Ontaneda, MD, PHD — The Cleveland Clinic
- Study coordinator: Meghan Kilbane
- Email: kilbanm@ccf.org
- Phone: 216-445-9845
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.